MTNB Stock Analysis: Buy, Sell, or Hold?
MTNB - Matinas BioPharma Holdings, Inc.
$0.59
-0.01 (-1.73%)
▼
5d:
-18.04%
30d:
-4.82%
90d:
-57.24%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Get Alerted When MTNB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MTNB is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MTNB is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MTNB is currently trading at $0.59, which is considered oversold relative to its 30-day fair value range of $0.60 to $0.70.
Technical Outlook: Technically, MTNB is in a strong downtrend. Immediate support is located at $0.56, while resistance sits at $0.79.
Market Sentiment: MTNB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+4983.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MTNB is in a strong downtrend. Immediate support is located at $0.56, while resistance sits at $0.79.
Market Sentiment: MTNB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+4983.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.60 -
$0.70
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 4983.9% below Wall St target ($30.00)
- WARNING: Recommendation downgraded due to -18.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.60 -
$0.70
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.56
Resistance Level
$0.79
Current Trend
Strong Downtrend
Fundamental Context
Wall Street Target
$30.00
(+4983.9%)
Revenue Growth (YoY)
-100.0%
Last updated: February 03, 2026 4:08 PM ET
Data refreshes hourly during market hours. Next update: 5:08 PM
Data refreshes hourly during market hours. Next update: 5:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTNB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 67 BUY |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 65 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 53 HOLD |
